OncoSec Medical Inc (ONCSQ)

[trading.jeff]

OncoSec Medical (ONCS) Given New $4.00 Price Target at HC Wainwright

OncoSec Medical (NASDAQ:ONCS) had its price target cut by investment analysts at HC Wainwright from $6.00 to $4.00 in a note issued to investors on Monday. The brokerage currently has a “buy” rating on the biotechnology company’s stock. HC Wainwright’s price objective would suggest a potential upside of 154.78% from the company’s current price.

Several other brokerages also recently issued reports on ONCS. Piper Jaffray initiated coverage on shares of OncoSec Medical in a research note on Friday, February 9th. They issued an “overweight” rating and a $4.00 price objective for the company. Maxim Group set a $5.00 price objective on shares of OncoSec Medical and gave the stock a “buy” rating in a research note on Monday, April 16th. One equities research analyst has rated the stock with a sell rating and five have assigned a buy rating to the company’s stock. The company has a consensus rating of “Buy” and an average price target of $4.50.

https://www.americanbankingnews.com/2018/04/23/oncosec-medical-oncs-given-new-4-00-price-target-at-hc-wainwright.html

$ONCS